Ovarian Cancer in the Older Manitoban Population-Treatment Tolerance and Cancer-Related Outcomes: A Manitoba Ovarian Cancer Outcomes (MOCO) Group Study

CONCLUSIONS: Our study demonstrated a high rate of chemotherapy dose reduction and discontinuation in the elderly epithelial ovarian cancer population. Further research is needed to identify risk factors for treatment discontinuation and intolerance in this population.PMID:38534935 | PMC:PMC10969362 | DOI:10.3390/curroncol31030102
Source: Current Oncology - Category: Cancer & Oncology Authors: Source Type: research